Bicycle Therapeutics plc

BCYC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$59,100-$78,952-$60,987-$51,854
Dep. & Amort.$1,756$1,696$1,640$1,688
Deferred Tax-$46-$331-$1,321-$1,034
Stock-Based Comp.$8,771$9,435$9,605$10,333
Change in WC-$22,554-$4,634-$35,675$35,931
Other Non-Cash$0$0$37-$4,460
Operating Cash Flow-$71,173-$72,786-$86,702-$9,360
Investing Activities
PP&E Inv.-$674-$498-$606-$368
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$674-$498-$606-$368
Financing Activities
Debt Repay.-$31-$46-$43-$42
Stock Issued$0$1$2-$2,001
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1-$0-$0$2,246
Financing Cash Flow-$30-$45-$41$203
Forex Effect-$1,249$1,807$802-$1,781
Net Chg. in Cash-$73,126-$71,522-$86,547-$11,342
Supplemental Information
Beg. Cash$721,998$793,520$879,520$891,409
End Cash$648,872$721,998$792,973$880,067
Free Cash Flow-$71,847-$73,284-$87,308-$9,764
Bicycle Therapeutics plc (BCYC) Financial Statements & Key Stats | AlphaPilot